Legorreta Pablo G.

CIK 00015076783 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001507678

Recent Transactions

50 trades

Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-05+36,559→ 940,955 total
Gift
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2025-08-08−60,000→ 692,701 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-08-06+21,901→ 904,396 total
Other
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2025-06-03−3,823,996→ 22,617,909 total
Conversion
PROKIDNEY CORP.$PROK
Class B Ordinary Shares
2025-06-03−3,823,996→ 84,283,430 total
Conversion
PROKIDNEY CORP.$PROK
Common Units in ProKidney LP
2025-06-03−3,823,996→ 84,283,430 total
Conversion
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2025-06-03+3,823,996→ 26,441,905 total
Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2025-05-29+125,862→ 125,862 total
Other
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-05-16+530,348→ 882,495 total
Other
Royalty Pharma plc$RPRX
Option (Right to Buy)
2025-05-16+857,138→ 857,138 total
Award
Royalty Pharma plc$RPRX
Class E Ordinary Shares
2025-05-16+13,356,742→ 13,356,742 total
Gift
Royalty Pharma plc$RPRX
Class B Ordinary Shares
2025-05-12−867,180→ 0 total
Gift
Royalty Pharma plc$RPRX
Class B Ordinary Shares
2025-05-12+867,180→ 0 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-05-08+288,352→ 352,147 total
Conversion
PROKIDNEY CORP.$PROK
Class B Ordinary Shares
2025-02-04−532,535→ 88,107,426 total
Other
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2025-02-04−532,535→ 22,617,909 total
Conversion
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2025-02-04+532,535→ 23,150,444 total
Conversion
PROKIDNEY CORP.$PROK
Common Units in ProKidney LP
2025-02-04−532,535→ 88,107,426 total
Purchase
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2024-06-13$2.42/sh+22,617,909→ 22,617,909 total
Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2024-05-30+62,558→ 62,558 total
Conversion
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2024-02-05+748,952→ 748,952 total
Conversion
PROKIDNEY CORP.$PROK
Common Units in ProKidney LP
2024-02-05−748,952→ 88,639,961 total
Other
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2024-02-05−748,952→ 0 total
Conversion
PROKIDNEY CORP.$PROK
Class B Ordinary Shares
2024-02-05−748,952→ 88,639,961 total
Other
Royalty Pharma plc$RPRX
Class A ordinary shares
2023-11-16−383,000→ 63,795 total
Conversion
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2023-10-30+5,289,055→ 5,289,055 total
Conversion
PROKIDNEY CORP.$PROK
Class B Ordinary Shares
2023-10-30−5,289,055→ 89,388,913 total
Conversion
PROKIDNEY CORP.$PROK
Common Units in ProKidney LP
2023-10-30−5,289,055→ 89,388,913 total
Other
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2023-10-30−5,289,055→ 0 total
Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2023-06-29+48,128→ 48,128 total
Purchase
Royalty Pharma plc$RPRX
Class A ordinary shares
2023-06-28$29.51/sh+130,000→ 600,000 total
Purchase
Royalty Pharma plc$RPRX
Class A ordinary shares
2023-06-13$32.78/sh+45,000→ 470,000 total
Purchase
Royalty Pharma plc$RPRX
Class A ordinary shares
2023-06-12$33.00/sh+45,000→ 425,000 total
Purchase
Royalty Pharma plc$RPRX
Class A ordinary shares
2023-05-24$32.25/sh+150,000→ 380,000 total
Purchase
Royalty Pharma plc$RPRX
Class A ordinary shares
2023-05-17$32.94/sh+69,612→ 230,000 total
Purchase
Royalty Pharma plc$RPRX
Class A ordinary shares
2023-05-16$33.57/sh+160,388→ 160,388 total
Gift
Royalty Pharma plc$RPRX
ICAI Interests
2023-05-12+10,269→ 692,701 total
Gift
Royalty Pharma plc$RPRX
ICAI Interests
2023-05-12−10,269→ 0 total
Gift
Royalty Pharma plc$RPRX
Class A ordinary shares
2022-12-30+292,190.49→ 292,190.49 total
Disposition to Issuer
Epizyme, Inc.
Restricted Stock Units
2022-08-12−8,994→ 0 total
Disposition from Tender
Epizyme, Inc.
Common Stock, par value $0.0001
2022-08-12−31,933,334→ 0 total
Gift
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2022-08-12−150,640→ 2,700,000 total
Disposition to Issuer
Epizyme, Inc.
Restricted Stock Units
2022-08-12−8,060→ 0 total
Award
PROKIDNEY CORP.$PROK
Class B Ordinary Shares
2022-07-11+94,677,968→ 94,677,968 total
Award
PROKIDNEY CORP.$PROK
Common Units in ProKidney LP
2022-07-11+94,677,968→ 94,677,968 total
Award
PROKIDNEY CORP.$PROK
Earnout Rights
2022-07-11+10,500,000→ 10,500,000 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2022-05-17$0.56/sh+41,006→ 41,006 total
Award
Epizyme, Inc.
Restricted Stock Units
2022-05-17+8,994→ 8,994 total
Other
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-04-14−462,031→ 0 total
Other
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-04-14−350,000→ 63,795 total

Companies

Recent Filings

Address

C/O ROYALTY PHARMA PLC 110 E. 59TH STREET

NEW YORK, NY, 10022

View on SEC.gov